Lenvatinib Combined Anti-PD1 Antibody for the Advanced Hepatocellular Carcinoma
Clinical trial NCT04627012 · COMPLETED
Trial details
- NCT number
- NCT04627012
- Sponsor
- Sun Yat-sen University
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-01-01
- Primary completion
- 2021-12-30
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.